The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8.

Zhang JY, Zhou B, Sun RY, Ai YL, Cheng K, Li FN, Wang BR, Liu FJ, Jiang ZH, Wang WJ, Zhou D, Chen HZ, Wu Q. · 2021

Read The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8. by Zhang JY, Zhou B, Sun RY, Ai YL, Cheng K, Li FN, Wang BR, Liu FJ, Jiang ZH, Wang WJ, Zhou D, Chen HZ, Wu Q. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8410789.txt.

Introduction

Zhang and co-authors show how a common metabolite can trigger a fiery form of cell death in cancer cells. Pyroptosis is a regulated death path run by gasdermin proteins. The role of one member, GSDMC, was not clear before this work.

The team found that alpha-ketoglutarate sets off pyroptosis through caspase-8 cutting GSDMC. A cell-ready form of the metabolite raised reactive oxygen levels. That oxidized the death receptor DR6 and pulled it inside the cell. There it gathered caspase-8 and GSDMC into one complex. In mouse models, this death path slowed tumor growth and spread. Acidic settings made the effect stronger.

Catalog record

CREATORZhang JY, Zhou B, Sun RY, Ai YL, Cheng K, Li FN, Wang BR, Liu FJ, Jiang ZH, Wang WJ, Zhou D, Chen HZ, Wu Q.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE88 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8410789

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8 By Jia-yuan Zhang, Bo Zhou, Ru-yue Sun, Yuan-li Ai, Kang Cheng, Fu-nan Li, Bao-rui Wang, Fan-jian Liu, Zhi-hong Jiang, Wei-jia Wang, Dawang Zhou, Hang-zi Chen Published in: Cell Research DOI: 10.1038/s41422-021-00506-9 ABSTRACT Pyroptosis is a form of regulated cell death mediated by gasdermin family members, among which the function of GSDMC has not been clearly described. Herein, we demonstrate that the metabolite α-ketoglutarate (α-KG) induces pyroptosis through caspase-8-mediated cleavage of GSDMC. Treatment with DM-αKG, a cell-permeable derivative of α-KG, elevates ROS levels, which leads to oxidation of the plasma membrane-localized death receptor DR6. Oxidation of DR6 triggers its endocytosis, and then recruits both pro-caspase-8 and GSDMC to a DR6 receptosome through protein-protein interactions. The DR6 receptosome herein provides a platform for the cleavage of GSDMC by active caspase-8, thereby leading to pyroptosis. Moreover, this α-KG-induced pyroptosis could inhibit tumor growth and metastasis in mouse models. Interestingly, the efficiency of α-KG in inducing pyroptosis relies on an acidic environment in which α-KG is reduced by MDH1 and converted to L-2HG that further boosts ROS levels. Treatment with lactic acid, the end product of glycolysis, builds an improved acidic environment to facilitate more production of L-2HG, which makes the originally pyroptosis-resistant cancer cells more susceptible to α-KG-induced pyroptosis. This study not only illustrates a pyroptotic pathway linked with metabolites but also identifies an unreported principal axis extending from ROS-initiated DR6 endocytosis to caspase-8-mediated cleavage of GSDMC for potential clinical application in tumor therapy. INTRODUCTION Cell death is a very complicated and important biological process that contributes to the regulation of various physiological functions and maintenance of body homeostasis. Dysregulation of cell death programming leads to the occurrence of various diseases, including cancers. Therefore, further understanding the functional mechanism and signaling pathways involved in cell death would benefit the treatment of various diseases. Pyroptosis is a form of regulated cell death mediated by gasdermin family proteins.1 In humans, the gasdermin family consists of six members: GSDM-A, -B, -C -D, -E (also called DFNA5), and DFNB59. Mice lack GSDMB but express three GSDMAs (mGSDMA1–3) and four GSDMCs (mGSDMC1–4).2 Structurally, all gasdermin family members except DFNB59 have an N-terminal pore-forming domain, a C-terminal autoinhibitory domain, and a loop domain that links the N- and C-terminal domains. Protease-mediated cleavage within the linker loop releases the N-terminal domain, which then oligomerizes to form nonselective pores at the plasma membrane and causes membrane permeability changes, cell swelling and membrane rupture. For example, inflammasome-activated caspase-1/4/5/11 cleave GSDMD to produce an N-terminal fragment that triggers pyroptosis,2–4 while proapoptotic stimuli activate caspase-3, which cleaves GSDME to induce pyroptosis.5,6 The functions of pyroptosis have become a hot spot in cancer research. The Shao group found that GSDME-mediated pyroptosis is associated with the side effects of chemotherapy. Following treatment with chemotherapeutic drugs, activated caspase-3 cleaves GSDME to induce pyroptosis in GSDME-expressing cells. Unfortunately, GSDME is silenced in most tumor cells but is highly expressed in normal cells and tissues, which leads to strong induction of pyroptosis in normal tissues upon the administration of chemotherapeutic drugs.5 Therefore, specifically inducing pyroptosis in tumor cells while avoiding normal cell and tissue damage has become a key issue. We previously demonstrated that iron reinforces the effect of ROS-inducing drugs in boosting ROS levels, leading to the activation of GSDME and pyroptosis of melanoma cells. Hence, iron supplementation was used as a sensitizer in combination with clinical drugs to inhibit the growth and metastasis of melanoma in a mouse model, with decreased toxicity.7 Although the currently limited research findings cannot fundamentally explain the two outcomes of pyroptosis in normal and tumor tissues, targeting pyroptosis for tumor therapy may be a good strategy, because pyroptosis of tumor cells would not only overcome the apoptosis resistance of tumor cells but also trigger antitumor immunity.8–11 However, the specific pyroptosis inducers in tumors are largely unknown. Cell fate is closely associated with metabolic homeostasis. α-Ketoglutarate (α-KG) is an essential metabolite in the tricarboxylic acid (TCA) cycle and plays a significant role in physiological processes, including lipid biosynthesis, oxidative stress reduction, protein modification, autophagy, and cell death. Several studies have shown that α-KG is a prospective antitumor agent. For example, α-KG suppresses breast cancer oncogenesis by switching metabolism from glycolysis to oxidative phosphorylation.12 Accumulated α-KG blocks malignant progression by driving tumor cell differentiation in p53-null tumors.13 Moreover, increasing the α-KG/succinate ratio by disrupting mitochondrial complex I suppresses tumor growth.14,15 However, the role of α-KG in pyroptosis remains unreported. The aim of this study was to investigate the molecular mechanism and signaling pathway of α-KG in pyroptotic cell death. We demonstrated that α-KG is promiscuously reduced to another metabolite, L-2HG, by the metabolic enzyme MDH1 in an acidic environment, which then increases ROS levels to induce the oxidation and internalization of the plasma membrane-localized death receptor DR6. Internalized DR6 further recruits both pro-caspase-8 and GSDMC to the DR6 receptosome that provides a platform for the cleavage of GSDMC by active caspase-8, thereby inducing pyroptosis. This pyroptosis was sufficient for the inhibition of tumor growth and metastasis in mouse models. Collectively, this study not only identifies the key node protein (DR6), pyroptosis initiator (caspase-8), and executor (GSDMC) in the α-KG-induced pyroptotic pathway but also provides an important research direction for clinical tumor treatment via pyroptosis induction. RESULTS α-KG induces pyroptosis through caspase-8-mediated cleavage of GSDMC The metabolite α-ketoglutarate (α-KG), a key metabolite in the TCA cycle, plays important roles in both metabolic and cellular pathways.16 Since exogenously added α-KG cannot pass through the cell membrane, we used dimethyl-α-ketoglutarate (DM-αKG, a cell-permeable analog of α-KG) to treat HeLa cervical carcinoma cells and unexpectedly found that DM-αKG significantly induced cell death with typical morphological features of pyroptosis, i.e., cell swelling and large areas of plasma membrane blebbing (Fig. 1a, left; pyroptotic cells are indicated with red arrows), accompanied by rupture of the cell membrane, as indicated by the release of LDH (Fig. 1a, right) and an increase in the Annv/PI double-positive cell population (Fig. 1b). This DM-αKG-induced pyroptotic morphology was also observed in many other cancer cell lines, including SGC-7901 and BGC-823 human gastric cancer cells, HCT116 human colon cancer cells, Huh7 human hepatoma cells and B16 mouse melanoma cells, although some other cancer cell lines were insensitive to DM-αKG (Supplementary information, Fig. S1a). Some nontumor cell lines, such as LX-2 human hepatic stellate cells, HaCaT human keratinocyte cells, HFL-1 human lung fibroblast cells, and L929 mouse fibroblast cells, were also resistant to DM-αKG (Supplementary information, Fig. S1b). These results indicated that α-KG can induce lytic cell death accompanied by a pyroptotic morphology in many cancer cell lines.Fig. 1α-KG induces pyroptosis by caspase-8 cleavage of GSDMC.HeLa cells were treated with DM-αKG (15 mM) for 24 h or the indicated times to assess pyroptotic features (including characteristic morphology, GSDMC cleavage, LDH release, and Annv+/PI+ cells), unless specially defined. a–c DM-αKG induced pyroptosis in HeLa cells. Pyroptotic morphology and LDH release (a), percentage of Annv+/PI+ cell population (b), and GSDMC cleavage (c) at different concentrations of DM-αKG as indicated in HeLa cells were shown. Red arrows indicate pyroptotic cells in a. Cells were stained with Annexin V (Annv) and propidium iodide (PI), then analyzed by flow cytometry in

Read the complete text